Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Lorlatinib market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Lorlatinibmarket, defines the market attractiveness level of Lorlatinib market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Lorlatinib industry, describes the types of Lorlatinib market, the applications of major players and the market size, and deeply analyzes the current situation of the global Lorlatinib market and the development prospects and opportunities of Lorlatinib industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Lorlatinib market in Chapter 13.
By Player:
Pfizer
By Type:
Tablets 25mg
Tablets 100mg
By End-User:
Squamous Cell Carcinoma of NSCLC
Adenocarcinoma of NSCLC
Large Cell Carcinoma of NSCLC
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Lorlatinib Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Lorlatinib Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Lorlatinib Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Lorlatinib Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Lorlatinib Market Analysis and Outlook to 2022
-
7.1 Global Lorlatinib Consumption (2017-2022)
-
7.2 United States Lorlatinib Consumption (2017-2022)
-
7.3 Europe Lorlatinib Consumption (2017-2022)
-
7.4 China Lorlatinib Consumption (2017-2022)
-
7.5 Japan Lorlatinib Consumption (2017-2022)
-
7.6 India Lorlatinib Consumption (2017-2022)
-
7.7 South Korea Lorlatinib Consumption (2017-2022)
8 Region and Country-wise Lorlatinib Market Analysis and Outlook to 2028
-
8.1 Global Lorlatinib Consumption Forecast (2022-2028)
-
8.2 United States Lorlatinib Consumption Forecast (2022-2028)
-
8.3 Europe Lorlatinib Consumption Forecast (2022-2028)
-
8.4 China Lorlatinib Consumption Forecast (2022-2028)
-
8.5 Japan Lorlatinib Consumption Forecast (2022-2028)
-
8.6 India Lorlatinib Consumption Forecast (2022-2028)
-
8.7 South Korea Lorlatinib Consumption Forecast (2022-2028)
9 Global Lorlatinib Market Outlook by Types and Applications to 2022
-
9.1 Global Lorlatinib Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tablets 25mg Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Tablets 100mg Consumption and Growth Rate (2017-2022)
-
9.2 Global Lorlatinib Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Squamous Cell Carcinoma of NSCLC Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Adenocarcinoma of NSCLC Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Large Cell Carcinoma of NSCLC Consumption and Growth Rate (2017-2022)
10 Global Lorlatinib Market Outlook by Types and Applications to 2028
-
10.1 Global Lorlatinib Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Tablets 25mg Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Tablets 100mg Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Lorlatinib Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Squamous Cell Carcinoma of NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Adenocarcinoma of NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Large Cell Carcinoma of NSCLC Consumption Forecast and Growth Rate (2022-2028)
11 Global Lorlatinib Import and Export Analysis (Top 5 Countries)
-
11.1 Global Lorlatinib Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Lorlatinib Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Lorlatinib Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Lorlatinib Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Lorlatinib Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Lorlatinib Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Lorlatinib
-
Figure Lorlatinib Picture
-
Table Global Lorlatinib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Lorlatinib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Lorlatinib Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Lorlatinib Consumption by Country (2017-2022)
-
Figure United States Lorlatinib Consumption and Growth Rate (2017-2022)
-
Table Europe Lorlatinib Consumption and Growth Rate (2017-2022)
-
Figure China Lorlatinib Consumption and Growth Rate (2017-2022)
-
Figure Japan Lorlatinib Consumption and Growth Rate (2017-2022)
-
Figure India Lorlatinib Consumption and Growth Rate (2017-2022)
-
Figure South Korea Lorlatinib Consumption and Growth Rate (2017-2022)
-
Figure Global Lorlatinib Consumption Forecast by Country (2022-2028)
-
Figure United States Lorlatinib Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Lorlatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Lorlatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Lorlatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Lorlatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Lorlatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tablets 25mg Consumption and Growth Rate (2017-2022)
-
Figure Global Tablets 100mg Consumption and Growth Rate (2017-2022)
-
Figure Global Squamous Cell Carcinoma of NSCLC Consumption and Growth Rate (2017-2022)
-
Figure Global Adenocarcinoma of NSCLC Consumption and Growth Rate (2017-2022)
-
Figure Global Large Cell Carcinoma of NSCLC Consumption and Growth Rate (2017-2022)
-
Figure Global Tablets 25mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tablets 100mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Squamous Cell Carcinoma of NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adenocarcinoma of NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Large Cell Carcinoma of NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Lorlatinib Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Lorlatinib Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Lorlatinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Lorlatinib Product and Service
-
